Following the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation...

An innovative algorithm enhances blood sugar management, reducing severe hyperglycemia and hypoglycemia in hospitalized patients.

A new study from the Karolinska Institutet, published in the journal eClinicalMedicine, reveals that GLP-1 agonists, a type of medication used to...

A recent study by the FDA, published in the Annals of Internal Medicine, has highlighted a significant health concern linked to a modern class of...

Recent research has concluded that two days a week of a medically supervised energy-restricted diet may lower blood glucose levels in adults with...

Diabetes is a common health condition where the body either can’t produce enough insulin or can’t use insulin effectively, leading to high levels...

A healthy diet that adheres to nutrition recommendations is associated with better blood glucose levels and a lower risk of prediabetes and type 2...

June 24, 2024 -- The U.S. Food and Drug Administration (FDA) has approved PiaSky (crovalimab-akkz) for the treatment of adult and pediatric patients...

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from...

The EXTOD faculty (www.extod.co.uk), a group of NHS and University based experts in T1D and exercise, are holding a number of one-day events to...